Attenuation of endoplasmic reticulum stress and mitochondrial injury in kidney with ischemic postconditioning application and trimetazidine treatment

Journal of Biomedical Science

Volumn 19, Issue 1, 2012, Pages

  Mahfoudh Boussaid, Asma ^a   Zaouali, Mohamed Amine ^b   Hauet, Thierry ^c   Hadj Ayed, Kaouther ^a   Miled, Abdel Hédi ^a   Ghoul Mazgar, Sonia ^d   Saidane Mosbahi, Dalila ^a   Rosello Catafau, Joan ^b   Abdennebi, Hassen Ben ^a  

^a UNIVERSITY OF MONASTIR   (Tunisia)

^b INST D INVESTIGACIONS B   (Spain)

^c UNIVERSITÉ DE POITIERS   (France)

^d UNIVERSITY OF MONASTIR   (Tunisia)

Author keywords

Endoplasmic reticulum stress; Ischemia reperfusion; Ischemic postconditioning; Kidney; Mitochondria; Trimetazidine

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 4; CYTOCHROME C; GLUCOSE REGULATED PROTEIN 78; GLYCOGEN SYNTHASE KINASE 3BETA; LACTATE DEHYDROGENASE; MALONALDEHYDE; PROTEIN KINASE R; STRESS ACTIVATED PROTEIN KINASE; TRIMETAZIDINE; VOLTAGE DEPENDENT ANION CHANNEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; CYTOLYSIS; DOWN REGULATION; DRUG EFFECT; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ISCHEMIC POSTCONDITIONING; KIDNEY FUNCTION; KIDNEY ISCHEMIA; MALE; MITOCHONDRIAL TOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SODIUM ABSORPTION; WESTERN BLOTTING; ANIMAL; INJURY; KIDNEY; METABOLISM; MITOCHONDRION; PATHOLOGY; WISTAR RAT;

RATTUS; RATTUS NORVEGICUS;

ANIMALS; ENDOPLASMIC RETICULUM STRESS; ISCHEMIC POSTCONDITIONING; KIDNEY; MITOCHONDRIA; RATS; RATS, WISTAR; REPERFUSION INJURY; TRIMETAZIDINE;

EID: 84864417085     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-19-71     Document Type: Article

References (43)

1. Postconditioning is an effective strategy to reduce renal ischaemia/reperfusion injury. Serviddio G, Romano AD, Gesualdo L, Tamborra R, Di Palma AM, Rollo T, Altomare E, Vendemiale G, Nephrol Dial Transplant 2008 23 1504 1512 10.1093/ndt/gfm779 18285396
2. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Murry CE, Jennings RB, Reimer KA, Circulation 1986 74 1124 1136 10.1161/01.CIR.74.5.1124 3769170
3. Renal protection by delayed ischaemic preconditioning is associated with inhibition of the inflammatory response and NF-kappaB activation. Jiang SH, Liu CF, Zhang XL, Xu XH, Zou JZ, Fang Y, Ding XQ, Cell Biochem Funct 2007 25 335 343 10.1002/cbf.1395 17221834
4. Ischemic postconditioning inhibits apoptosis after renal ischemia/reperfusion injury in rat. Chen H, Xing B, Liu X, Zhan B, Zhou J, Zhu H, Chen Z, Transpl Int 2008 21 364 371 10.1111/j.1432-2277.2007.00606.x 18069925
5. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Zhao ZQ, Corvera JS, Halkos ME, Kerendi F, Wang NP, Guyton RA, Vinten-Johansen J, Am J Physiol Heart Circ Physiol 2003 285 579 H588 12860564
6. Ischemic postconditioning protects brain from ischemia/reperfusion injury by attenuating endoplasmic reticulum stress-induced apoptosis through PI3K-Akt pathway. Yuan Y, Guo Q, Ye Z, Pingping X, Wang N, Song Z, Brain Res 2011 1367 85 93 20940001
7. Role of mitochondria in cell apoptosis during hepatic ischemia-reperfusion injury and protective effect of ischemic postconditioning. Sun K, Liu ZS, Sun Q, World J Gastroenterol 2004 10 1934 1938 15222040
8. Attenuation of reperfusion injury by renal ischemic postconditioning: The role of NO. Liu X, Chen H, Zhan B, Xing B, Zhou J, Zhu H, Chen Z, Biochem Biophys Res Commun 2007 359 628 634 10.1016/j.bbrc.2007.05.129 17548062
9. Attenuation of renal ischemia-reperfusion injury by postconditioning involves adenosine receptor and protein kinase C activation. Eldaif SM, Deneve JA, Wang NP, Jiang R, Mosunjac M, Mutrie CJ, Guyton RA, Zhao ZQ, Vinten-Johansen J, Transpl Int 2009 23 217 226 19725910
10. Ischemic postconditioning protects myocardium from ischemia/reperfusion injury through attenuating endoplasmic reticulum stress. Liu XH, Zhang ZY, Sun S, Wu XD, Shock 2008 30 422 427 10.1097/SHK.0b013e318164ca29 18323739
11. Perturbations in maturation of secretory proteins and their association with endoplasmic reticulum chaperones in a cell culture model for epithelial ischemia. Kuznetsov G, Bush KT, Zhang PL, Nigam SK, Proc Natl Acad Sci U S A 1996 93 8584 8589 10.1073/pnas.93.16.8584 8710914
12. Endoplasmic reticulum stress as a novel therapeutic target in heart diseases. Toth A, Nickson P, Mandl A, Bannister ML, Toth K, Erhardt P, Cardiovasc Hematol Disord Drug Targets 2007 7 205 218 10.2174/187152907781745260 17896961
13. Endoplasmic reticulum calcium release potentiates the ER stress and cell death caused by an oxidative stress in MCF-7 cells. Dejeans N, Tajeddine N, Beck R, Verrax J, Taper H, Gailly P, Calderon PB, Biochem Pharmacol 2010 79 1221 1230 10.1016/j.bcp.2009.12.009 20006589
14. Endoplasmic reticulum stress in the kidney as a novel mediator of kidney injury. Inagi R, Nephron Exp Nephrol 2009 112 1 e9 10.1159/000210573 19342868
15. Transcriptional induction of mammalian ER quality control proteins is mediated by single or combined action of ATF6alpha and XBP1. Yamamoto K, Sato T, Matsui T, Sato M, Okada T, Yoshida H, Harada A, Mori K, Dev Cell 2007 13 365 376 10.1016/j.devcel.2007.07.018 17765680
16. ATF6 is a transcription factor specializing in the regulation of quality control proteins in the endoplasmic reticulum. Adachi Y, Yamamoto K, Okada T, Yoshida H, Harada A, Mori K, Cell Struct Funct 2008 33 75 89 10.1247/csf.07044 18360008
17. Trimetazidine, administered at the onset of reperfusion, ameliorates myocardial dysfunction and injury by activation of p38 mitogen-activated protein kinase and Akt signaling. Khan M, Meduru S, Mostafa M, Khan S, Hideg K, Kuppusamy P, J Pharmacol Exp Ther 2010 333 421 429 10.1124/jpet.109.165175 20167841
18. Hypoxia inducible factor-1alpha accumulation in steatotic liver preservation: role of nitric oxide. Zaouali MA, Ben Mosbah I, Boncompagni E, Ben Abdennebi H, Mitjavila MT, Bartrons R, Freitas I, Rimola A, Rosellá-Catafau J, World J Gastroenterol 2010 16 3499 3509 10.3748/wjg.v16.i28.3499 20653058
19. Trimetazidine reduces early and long-term effects of experimental renal warm ischemia: a dose effect study. Cau J, Favreau F, Tillement JP, Lerman LO, Hauet T, Goujon JM, J Vasc Surg 2008 47 852 860 10.1016/j.jvs.2007.10.036 18280092
20. Pharmacological limitation of damage to renal medulla after cold storage and transplantation by trimetazidine. Hauet T, Baumert H, Amor IB, Gibelin H, Tallineau C, Eugene M, Tillement JP, Carretier M, J Pharmacol Exp Ther 2000 292 254 260 10604955
21. Evidence for a mitochondrial impact of trimetazidine during cold ischemia and reperfusion. Baumert H, Faure JP, Zhang K, Petit I, Goujon JM, Dutheil D, Favreau F, Barrière M, Tillement JP, Mauco G, Papadopoulos V, Hauet T, Pharmacology 2004 71 25 37 10.1159/000076259 15051920
22. Comparison of protective effects of trimetazidine against experimental warm ischemia of different durations: early and long-term effects in a pig kidney model. Jayle C, Favreau F, Zhang K, Doucet C, Goujon JM, Hebrard W, Carretier M, Eugene M, Mauco G, Tillement JP, Hauet T, Am J Physiol Renal Physiol 2007 292 1082 F1093 17341718
23. Effect of trimetazidine on xanthine oxidoreductase expression in rat kidney with ischemia reperfusion injury. Sulikowski T, Domanski L, Ciechanowski K, Adler GZ, Pawlik A, Safranow K, Dziedziejko V, Chlubek D, Ciechanowicz A, Arch Med Res 2008 39 459 462 10.1016/j.arcmed.2008.01.005 18375259
24. Trimetazidine: is it a promising drug for use in steatotic grafts? Ben Mosbah I, Casillas-Ramírez A, Xaus C, Serafín A, Rosellá-Catafau J, Peralta C, World J Gastroenterol 2006 12 908 914 16521219
25. An experimental model for assessment of renal recovery from warm ischemia. Jablonski P, Howden BO, Rae DA, Birrell Birrell CS, Marshall VC, Tange J, Transplantation 1983 35 198 204 10.1097/00007890-198303000-00002 6340272
26. Bcl-xL augmentation potentially reduces ischemia/reperfusion induced proximal and distal tubular apoptosis and autophagy. Chien CT, Shyue SK, Lai MK, Transplantation 2007 84 1183 1190 10.1097/01.tp.0000287334.38933.e3 17998875
27. Protective effect of nitric oxide pathway in resveratrol renal ischemia-reperfusion injury in rats. Chander V, Chopra K, Arch Med Res 2006 37 19 26 10.1016/j.arcmed.2005.05.018 16314181
28. Preconditioning with endoplasmic reticulum stress ameliorates mesangioproliferative glomerulonephritis. Inagi R, Kumagai T, Nishi H, Xu XH, Zou JZ, Fang Y, Ding XQ, J Am Soc Nephrol 2008 19 915 922 10.1681/ASN.2007070745 18256359
29. Hypoxic preconditioning reinforces HIF-alpha-dependent HSP70 signaling to reduce ischemic renal failure-induced renal tubular apoptosis and autophagy. Yeh CH, Hsu SP, Yang CC, Chien CT, Wang NP, Life Sci 2010 86 115 123 10.1016/j.lfs.2009.11.022 19962996
30. Role of the endoplasmic reticulum unfolded protein response in glomerular epithelial cell injury. Cybulsky AV, Takano T, Papillon J, Bijian K, J Biol Chem 2005 280 24396 24403 10.1074/jbc.M500729200 15863508
31. PERK is activated differentially in peripheral organs following cardiac arrest and resuscitation. Montie HL, Haezebrouck AJ, Gutwald JC, De Gracia DJ, Resuscitation 2005 66 379 389 10.1016/j.resuscitation.2005.03.014 16029920
32. ER stress and SREBP-1 activation are implicated in beta-cell glucolipotoxicity. Wang H, Kouri G, Wollheim CB, J Cell Sci 2005 118 3905 3915 10.1242/jcs.02513 16091421
33. The nephroprotective effect of taurousodeoxycholic acid on ischemia /reperfusion-induced acute kidney injury by inhibiting endoplasmic reticulum stress. Gao X, Fu L, Xiao M, Xu C, Sun L, Zhang T, Zheng F, Mei C, Basic Clin Pharmacol Toxicol in press
34. Oxidative damage to sarcoplasmic reticulum Ca2+ATPase AT submicromolar iron concentrations: evidence for metal-catalyzed oxidation. Moreau VH, Castilho RF, Ferreira ST, Carvalho-Alves PC, Free Radic Biol Med 1998 25 554 560 10.1016/S0891-5849(98)00084-7 9741592
35. Free radical-induced protein modification and inhibition of Ca2+ATPase of cardiac sarcoplasmic reticulum. Kaplan P, Babusikova E, Lehotsky J, Dobrota D, Mol Cell Biochem 2003 248 41 47 10.1023/A:1024145212616 12870653
36. Modulation of endoplasmic reticulum-bound cholesterol regulatory enzymes by iron/ascorbate-mediated lipid peroxidation. Brunet S, Thibault L, Lepage G, Seidman EG, Dubé N, Levy E, Free Radic Biol Med 2000 28 46 54 10.1016/S0891-5849(99)00197-5 10656290
37. The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase. Kantor PF, Lucien A, Kozak R, Lopaschuk GD, Circ Res 2000 86 580 588 10.1161/01.RES.86.5.580 10720420
38. Effect of trimetazidine on mitochondrial function and oxidative damage during reperfusion of ischemic hypertrophied rat myocardium. Guarnieri C, Muscari C, Pharmacology 1993 46 324 331 10.1159/000139070 8516381
39. Mitochondria as target for antiischemic drugs. Morin D, Hauet T, Spedding M, Tillement J, Adv Drug Deliv Rev 2001 49 151 174 10.1016/S0169-409X(01)00132- 6 11377809
40. Effect of trimetazidine on the nucleotide profile in rat kidney with ischemia-reperfusion injury. Domanski L, Sulikowski T, Safranow K, Pawlik A, Olszewska M, Chlubek D, Urasinska E, Ciechanowski K, Eur J Pharm Sci 2006 27 320 327 10.1016/j.ejps.2005.10.012 16387483
41. Evidence for the existence of [3H]-trimetazidine binding sites involved in the regulation of the mitochondrial permeability transition pore. Morin D, Elimadi A, Sapena R, Crevat A, Carrupt PA, Testa B, Tillement JP, Br J Pharmacol 1998 123 1385 1394 10.1038/sj.bjp.0701755 9579734
42. Role of glycogen synthase kinase-3 in cardioprotection. Juhaszova M, Zorov DB, Yaniv Y, Nuss HB, Wang S, Sollott SJ, Circ Res 2009 104 1240 1252 10.1161/CIRCRESAHA.109.197996 19498210
43. AMPK-associated signaling to bridge the gap between fuel metabolism and hepatocyte viability. Yang YM, Han CY, Kim YJ, Kim SG, World J Gastroenterol 2010 16 3731 3742 10.3748/wjg.v16.i30.3731 20698033